WARRINGTON, Pa., July 20, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced John Hamill has been appointed Senior Vice President, Chief Financial Officer. In this role, Mr. Hamill will […]
Author: Ken Dropiewski
VectraCor and GS GmbH (Corpuls) Form Licensing Agreement to Incorporate VectraCor’s 22-Lead ECG and CEB® (Cardiac Electrical Biomarker) Technology in Corpuls Defibrillators
Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 16, 2020 /PRNewswire/ — GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today that they have concluded a licensing agreement allowing corpuls to incorporate VectraCor’s […]
LivaNova announces the commercial launch of the Perceval Plus aortic valve in Europe
Next generation sutureless surgical technology is based on a clinically proven platform and has been designed to provide valve durability LONDON – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leading medical technology and innovation company, announced today that the Perceval ® Plus Advanced Suture-Free Surgical Aortic Valve is now available for a commercial […]
Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition – A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence
New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities TUSTIN, Calif.–(BUSINESS WIRE)–To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete […]
PhaseBio Doses First Patient in VANGARD Phase 2 Clinical Trial to Evaluate PB1046 for Hospitalized COVID-19 Patients
Recently launched Phase 2 “VANGARD” trial to assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome PB1046, a long-acting analog of vasoactive intestinal peptide (VIP), has the potential to modulate several proinflammatory cytokines that are believed […]
BioSig Technologies, Inc. Adopts Stockholder Rights Agreement
Westport, CT, July 16, 2020 (GLOBE NEWSWIRE) — Rights Agreement designed to assure stockholders receive fair and equal treatment in the event of any proposed takeover Provides a guard against tactics to gain control of the Company without paying stockholders a market premium for that control BioSig Technologies, Inc. (NASDAQ: […]
DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE UNIVERSITY MEDICAL CENTER TO GUIDE VOLUME TREATMENT IN HEART FAILURE PATIENTS
Enrollment Commences Using the BVA-100® Diagnostic Blood Test NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the initiation of a prospective randomized control trial (RTC) utilizing Daxor’s BVA-100 (Blood […]
Cardiva Medical Announces First Patients Enrolled in The AMBULATE Same Day Discharge Study Using VASCADE® MVP
First Prospective Multi-Center Study Evaluating Same Day Discharge for Patients Undergoing Cardiac Ablation Procedures for Atrial Fibrillation SANTA CLARA, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the first patient enrollments in its AMBULATE Same Day Discharge study, […]
Johnson & Johnson Reports 2020 Second-Quarter Results:
– Sales of $18.3 billion reflecting a decline of 10.8%, operational decline of 9.0%* and adjusted operational decline of 8.8%*, primarily driven by the negative impact of the COVID-19 pandemic – EPS of $1.36 decreased 34.6%; adjusted EPS of $1.67 decreased 35.3%*; 2019 included gain from sale of Advanced Sterilization […]
XACT ACE™ Robotic System Cleared by FDA for Image-Guided Percutaneous Procedures
– Hands-free robotic system combines image-based planning and navigation with instrument insertion and steering delivering procedural Accuracy, Consistency and Efficiency – – ACE’s compact, mobile design, coupled with its ease of use and remote procedure capabilities, enable providers to safely treat a broad range of patient care needs in multiple sites […]
Recent
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Popular
- No commented posts yet